Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Volume 17, Issue 5, May 2020 - First Report Managed Care

Featured Article

Maneuvering the Rising Costs of Cancer
05/18/2020

Paul Nicolaus

Paul Nicolaus
New and improved cancer treatments have the potential to save lives, but only for those who can afford the seemingly ever-growing price tag. Experts break down the financial challenges faced by payers and predict what managed care markets may...
New and improved cancer treatments have the potential to save lives, but only for those who can afford the seemingly ever-growing price tag. Experts break down the financial challenges faced by payers and predict what managed care markets may...
New and improved cancer...
05/18/2020
First Report Managed Care

Department

Conference Insider
06/22/2020
Using a case-example of opioid medication classification for use in pain medicine outcomes research, researchers demonstrated in a presentation at the American Academy of Pain Medicine’s 36th Annual Meeting, that the application of machine...
Using a case-example of opioid medication classification for use in pain medicine outcomes research, researchers demonstrated in a presentation at the American Academy of Pain Medicine’s 36th Annual Meeting, that the application of machine...
Using a case-example of opioid...
06/22/2020
First Report Managed Care
Conference Insider
06/22/2020
A study presented at the American Academy of Pain Medicine’s 36th Annual Meeting explored the association between emergency room (ER) triage, level of acuity, and opioid administration. 
A study presented at the American Academy of Pain Medicine’s 36th Annual Meeting explored the association between emergency room (ER) triage, level of acuity, and opioid administration. 
A study presented at the...
06/22/2020
First Report Managed Care
Conference Insider
06/22/2020
Researchers presented at the American Academy of Pain Medicine’s 36th Annual Meeting a poster titled, “Integrated Interventions to Increase Compliance with Practice Guidelines for Opioid Prescribing for Chronic, Non-Cancer-Associated Pain in...
Researchers presented at the American Academy of Pain Medicine’s 36th Annual Meeting a poster titled, “Integrated Interventions to Increase Compliance with Practice Guidelines for Opioid Prescribing for Chronic, Non-Cancer-Associated Pain in...
Researchers presented at the...
06/22/2020
First Report Managed Care
Conference Insider
06/22/2020
Increasing out-of-pocket costs has minimal effect on prescription opioid use, according to a poster presented at the American Academy of Pain Medicine’s 36th Annual Meeting.
Increasing out-of-pocket costs has minimal effect on prescription opioid use, according to a poster presented at the American Academy of Pain Medicine’s 36th Annual Meeting.
Increasing out-of-pocket costs...
06/22/2020
First Report Managed Care
Conference Insider
06/22/2020
Researchers recently presented at the American Academy of Pain Medicine’s 36th Annual Meeting on the association of systemic opioid prescribing patterns and total cost of care for patients beginning spinal cord stimulation (SCS) therapy. 
Researchers recently presented at the American Academy of Pain Medicine’s 36th Annual Meeting on the association of systemic opioid prescribing patterns and total cost of care for patients beginning spinal cord stimulation (SCS) therapy. 
Researchers recently presented...
06/22/2020
First Report Managed Care
Conference Insider
06/22/2020
Back pain is one of the top pain complaints in the United States and simultaneously one of the most common reason for patient presentation in the emergency department (ED). A study presented at the American Academy of Pain Medicine’s 36th...
Back pain is one of the top pain complaints in the United States and simultaneously one of the most common reason for patient presentation in the emergency department (ED). A study presented at the American Academy of Pain Medicine’s 36th...
Back pain is one of the top pain...
06/22/2020
First Report Managed Care
Conference Insider
06/22/2020
Triptans are among the most commonly prescribed medication class for acute treatment for patients presenting with migraine attacks but researchers recently presented at the AAN 2020 Annual Meeting on the effects on health care resource...
Triptans are among the most commonly prescribed medication class for acute treatment for patients presenting with migraine attacks but researchers recently presented at the AAN 2020 Annual Meeting on the effects on health care resource...
Triptans are among the most...
06/22/2020
First Report Managed Care
Conference Insider
06/22/2020
Managing migraine is associated with substantial economic burden prompting researchers to examine the association between overall health care resource utilization (HCRU) and treatment failure. 
Managing migraine is associated with substantial economic burden prompting researchers to examine the association between overall health care resource utilization (HCRU) and treatment failure. 
Managing migraine is associated...
06/22/2020
First Report Managed Care
Conference Insider
06/22/2020
According to science presented at the AAN 2020 Annual Meeting, rapid MRI is a cost-effective diagnosis method in the emergency department evaluation of suspected stroke patients.  Adam de Havenon, MD, University of Utah, and colleagues,...
According to science presented at the AAN 2020 Annual Meeting, rapid MRI is a cost-effective diagnosis method in the emergency department evaluation of suspected stroke patients.  Adam de Havenon, MD, University of Utah, and colleagues,...
According to science presented...
06/22/2020
First Report Managed Care
Conference Insider
06/22/2020
After a phase 3 clinical trial showed that olaparib is a successful maintenance therapy for patients with newly diagnosed advanced ovarian cancer and a germline or somatic BRCA mutation, researchers examined its overall cost-effectiveness...
After a phase 3 clinical trial showed that olaparib is a successful maintenance therapy for patients with newly diagnosed advanced ovarian cancer and a germline or somatic BRCA mutation, researchers examined its overall cost-effectiveness...
After a phase 3 clinical trial...
06/22/2020
First Report Managed Care

Advertisement

Advertisement

Advertisement